We report a hepatocellular carcinoma that appeared to undergo spontaneous regression twice. On June 5, 1995, two hepatocellular carcinomas were detected by ultrasonography in a 72-year-old woman. On July 1, 1995, the tumor in the lateral segment had increased in size from 2.0 cm to 3.2 cm in 27 days, and the level of α-fetoprotein (AFP) had increased from 743 to 1300 ng/ml. On September 22, 1995, one tumor appeared as a typical hypervascular lesion on contrast-enhanced computed tomography. It was 3.9 cm in size and located in the posterior segment. The other was a 3.9-cm cystic mass located in the lateral segment. The tumor in the posterior segment was treated with an emulsion of epirubicin and lipiodol administered via the posterior branch of the right hepatic artery and percutaneous ethanol injection. The tumor in the lateral segment was kept under observation because it was avascular, had regressed to 2.0 cm in size, and the patient's AFP level had decreased to 237 ng/ml by December 5, 1995. By February 21, 1996, the AFP level had increased again to 10 5340 ng/ml, and by March 22, 1996, the latter tumor had increased in size to 3.8 cm. However, it later regressed again to 1.6 cm, and the AFP level decreased spontaneously to 7 ng/ml. From the changes in the contrast-enhanced computed tomographic images, and the level of AFP, we cannot rule out the possibility that the spontaneous regression might have been caused by the tumor's rapid growth.
INTRODUCTION
We report a hepatocellular carcinoma (HCC) that grew rapidly and resulted in a cystic mass, but then decreased in size. Furthermore, this tumor regrew and again regressed spontaneously. This article describes the changes observed in contrast-enhanced computed tomographic (CT) images and the possible mechanism of the spontaneous regression of this HCC.
CASE REPORT
A 72-year-old Japanese woman with liver cirrhosis and diabetes was treated as an outpatient at Tobu Kawama Clinic. On June 5, 1995, two HCCs were detected by ultrasonography (US). One 2.0-cm tumor was located in the lateral segment of the liver, and a second 2.0-cm tumor was visualized in the posterior segment. The serum level of α-fetoprotein (AFP) was 743 ng/ml.
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The patient was therefore referred to Noda Hospital, on June 17 (13 days after detection), CT was performed. Contrast-enhanced CT scans were done after administration of 50 ml of contrast medium (total 100 ml) using drip infusion. The tumor in the lateral segment appeared as a faint low-density area (Fig. 1a) , and the tumor in the posterior segment could not be recognized. The HCCs were thought to be unresectable because of severe liver dysfunction. However, the two tumors subsequently grew. On June 1 (27 days after tumor detection), the tumor in the lateral segment was clearly recognizable at 3.2 cm in diameter with ring enhancement and a central low-density area (Fig. 1b) . The doubling time of this tumor was 8.7 days. On August 11 (69 days after tumor detection), this tumor was revealed to be 3.9 cm in size, with a large central, irregular, low-density area suggesting necrosis (Fig. 1c) . The serum level of AFP was 2400 ng/ml on August 31 (88 days after tumor detection).
On September 20, 1995 (108 days after tumor detection), the patient was referred to the National Cancer Center Hospital East for further evaluation and treatment of the two HCCs.
At the time of admission, the patient was asymptomatic. She had received a blood transfusion during gastrectomy for a gastric ulcer at the age of age 52, and in addition had undergone left mastectomy because of breast cancer on August 30, 1991. After Figure 1 . Contrast-enhanced computed tomography carried out on June 17, 1995, shows a tumor in the lateral segment of the liver which appears as a faint, ill-defined low-density area (a). By July 1, 1995, the tumor in the lateral segment was clearly recognizable as being 3.2 cm in size with ring enhancement and a central low-density area (b). On August 11, 1995, the tumor was 3.9 cm in size and had a large central, irregular, low-density area suggesting necrosis (c).
the mastectomy, tamoxifen and fluorouracil had been administered. However, the patient stopped taking these medications on February 12, 1992, because of anorexia and nausea. Only gliclazide was administered to treat her diabetes. She had never drunk alcohol.
Physical examination revealed surgical scars on the left side of the chest wall and abdominal wall. Abnormal laboratory data on admission (September 20, 1995) were as follows: platelet count, 9.1 × 104 platelets/µl; rate of prothombin time, 51.4%; total protein, 6.4 g/dl; albumin, 3.6 g/dl; total bilirubin, 1.8 mg/dl; aspartate aminotransferase, 63 IU/l; alanine aminotransferase, 35 IU/l; alkaline phosphatase, 289 IU/l; glucose, 286 mg/dl; AFP, 599 ng/ml. Hepatitis-B surface antigen was negative, and hepatitis-C virus antibody was positive.
On September 20 (108 days after tumor detection), US revealed two tumors with mosaic echo patterns and halo; one was 3.8 cm in size in the lateral segment of the liver (Fig. 2 ) and the other measured 3.2 cm in the posterior segment of the liver. On September 22 (110 days after tumor detection), the tumor in the lateral segment was recognizable as a low-density mass by plain CT, and as a cystic mass with partial ring enhancement both in the early and the late phases (Fig. 3a) . The early phase of contrastenhanced CT was performed 30 s after administration of 120 ml of contrast medium at a rate of 2.5 ml/s. The late phase of contrast-enhanced CT was performed 5 min later. Angiography was performed on October 5 (125 days after tumor detection). There were no abnormal vessels in the lateral segment. At that time, an emulsion consisting of 50 mg of epirubicin, and 5 ml of lipiodol, was administered via the posterior branch of the right hepatic artery. The tumor in the lateral segment was not treated because it was recognized to be radiolucent. Biopsy was performed for the tumor in the lateral segment including the halo portion on October 12 (132 days after tumor detection). Examination revealed that most of the specimen was necrotic, although part of it contained poorly differentiated HCC. From October 12 to December 6 (155 days after tumor detection), the tumor in the posterior segment was treated with percutaneous ethanol injection totaling 57 ml. However, because the tumor in the lateral segment appeared on US to have shrunk, and we therefore decided to keep it under observation without treatment. On November 24 (173 days after tumor detection), the patient's serum AFP level was 236 ng/ml. On December 5, 1995 (187 days after tumor detection), the tumor in the lateral segment had decreased in size to 2.0 cm with partial ring enhancement in the early phase and ring enhancement in the late phase (Fig. 3b) .
On February 21, 1996 (262 days after tumor detection), the AFP level had increased to 105 340 ng/ml. At that time, we surveyed the entire body but discovered no distant metastases. On March 12 (283 days after tumor detection), the tumor in the lateral segment had increased in size to 3.8 cm and had become multinodular with faint, partial, irregular ring enhancement in the early phase and irregular ring enhancement in the late phase (Fig. 3c) . From December 5, 1995 until March 12, 1996 , the doubling time of this tumor was 17.2 days. Once again, we kept the tumor under observation, since on May 1 (271 days after tumor detection), the AFP level had decreased to 34 964 ng/ml. Thereafter, the AFP level decreased rapidly. On May 16 (347 days after tumor detection), the tumor had decreased in size to 1.6 cm with ring enhancement (Fig. 3d) , and on June 7 (398 days after tumor detection), the AFP level had decreased to 7 ng/ml. The changes in tumor size and AFP levels are shown in Fig. 4 . At the time of writing, the patient is alive without any symptoms.
DISCUSSION
Everson and Cole (1) considered regression of cancer to be spontaneous if it occurred without administration of anticancer drugs or surgical resection. There have been 10 reports of spontaneous regression of HCC in the English-language literature (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . In the present case, there were two HCCs in separate lobes of the liver. To treat the tumor in the posterior segment, epirubicin was administered via the posterior branch of the right hepatic artery and percutaneous ethanol was injected. Therefore, the tumor in the lateral segment had regressed. Although the first episode of regression does not meet the criteria of spontaneous regression defined by Everson and Cole, the second episode can be considered to have been spontaneous. On admission, the tumor in the lateral segment was revealed to be avascular by both CT and angiography. Even though we had used an anticancer drug, the first regression of the lateral segment tumor was assumed to be spontaneous because its appearance of CT changed to one of a low-density mass suggesting necrosis, and most of the specimen obtained by liver biopsy was necrotic.
We believe this case is interesting because the growth and avascular transformation of this HCC was followed using CT. To our knowledge, no previous report has included a sequential series of radiographic images of the development of an avascular HCC. Twenty-seven days after the HCC had been first detected, it appeared heterogeneous with suspected central necrosis on CT. Three months later, the tumor had grown larger and appeared homogeneous and cystic on CT. Furthermore, it had then regressed to 2.0 cm in size, and US revealed a mosaic echo pattern. If CT scans had been obtained with lower window levels and wide window widths, cyst formation in the tumor would have shown a mosaic pattern, as on US.
Numerous mechanisms for spontaneous regression of HCC have been suggested. These include iatrogenic causes such as subintimal damage during angiography (12) and blood transfusion (13) . Other suggested causes include abstinence from alcohol (11, 14) , gastrointestinal bleeding (6,7), infection (15) , arterial thrombus (9) and rapid tumor growth (5). In our patient, angiography and blood transfusion were not performed and gastrointestinal bleeding, abstinence from alcohol and infection were not related factors during the 4-years follow-up. Furthermore, angiography revealed no major arterial thrombus. The main characteristic of the tumor in the lateral segment was that doubling times were short before the episode of spontaneous regression. Although Yoshino has reported that the mean doubling time of HCC is 119 days (16) ; the doubling time in the present tumor was considerably shorter. Therefore, as Suzuki et al. (5) have suggested, we cannot rule out the possibility that the cystic development of this tumor might have been due to its sudden rapid growth, and that the second episode of regression might have been caused by rapid growth in view of the changes in the level of AFP.
